Quarry LP’s SpringWorks Therapeutics SWTX Stock Holding History

Quarry LP’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-12,000	Closed	-$564K	–	2491
2025 Q2	$564K	Buy	12,000 +8,400	+233%	+$374K	0.12%	139
2025 Q1	$159K	Sell	3,600 -6,400	-64%	-$295K	0.03%	356
2024 Q4	$361K	Buy	10,000 +4,000	+67%	+$140K	0.05%	186
2024 Q3	$192K	Buy	6,000 +1,000	+20%	+$37.4K	0.05%	244
2024 Q2	$188K	Buy	5,000 +1,800	+56%	+$75.8K	0.05%	180
2024 Q1	$158K	Sell	3,200 -550	-15%	-$25.4K	0.03%	196
2023 Q4	$137K	Sell	3,750 -769	-17%	-$20.1K	0.02%	177
2023 Q3	$104K	Buy	+4,519	New	+$124K	0.02%	193

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Quarry LP's SWTX Position: Q3 2025 in Review

Quarry LP sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 12,000 shares — an estimated $564K sold.

Quarry LP first reported a position in SWTX in Q3 2023 and held it in 8 quarters. The position peaked at $564K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Quarry LP reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Quarry LP sold 12,000 SpringWorks Therapeutics shares in Q3 2025, an estimated $564K.
Quarry LP first reported a position in SpringWorks Therapeutics in Q3 2023 and held it in 8 quarters.
Quarry LP's SpringWorks Therapeutics position peaked at $564K in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Quarry LP's 13F filing for Q3 2025, filed 14 Nov 2025.